Tris-dichloroglyoximate clathrochelate [Fe(Cl2Gm)3(SnCl3)2]2− dianion has been synthesized by a procedure differing from those described earlier for boron-capped analogs. The co-ordinately saturated SnCl62− dianion is now used as the capping agent instead of boron-containing Lewis acids. The tris-dichloroglyoximate tin-capped product obtained is far less reactive than its boron-capped analogs, and only in the case of a thiophenolate anion was the “regular” hexafunctionalized clathrochelate obtained. The complexes synthesized have been characterized by elemental analysis, PD and MALDI-TOF mass, IR, UV-vis and 1H, 13C and 119Sn NMR spectra, cyclic voltammetry, and X-ray crystallography for the clathrochelate [Fe(Cl2Gm)3(SnCl3)2]2− dianion. The geometry of the functionalized complex (the distortion angle φ and main bond lengths in the clathrochelate framework) has been deduced from the quadrupole splitting value in the 57Fe Mössbauer spectrum and EXAFS data, respectively.
No takes yet. Share an insight, caveat, or question.
Voloshin et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: